IL103205A0 - Compounds for treating leukotriene-related diseases - Google Patents
Compounds for treating leukotriene-related diseasesInfo
- Publication number
- IL103205A0 IL103205A0 IL103205A IL10320592A IL103205A0 IL 103205 A0 IL103205 A0 IL 103205A0 IL 103205 A IL103205 A IL 103205A IL 10320592 A IL10320592 A IL 10320592A IL 103205 A0 IL103205 A0 IL 103205A0
- Authority
- IL
- Israel
- Prior art keywords
- compounds
- related diseases
- treating leukotriene
- leukotriene
- treating
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US76271091A | 1991-09-19 | 1991-09-19 | |
US79093191A | 1991-11-12 | 1991-11-12 | |
US80959391A | 1991-12-18 | 1991-12-18 | |
US93286992A | 1992-08-20 | 1992-08-20 | |
CN93103596A CN1092409A (en) | 1991-09-19 | 1993-03-19 | The compound that is used for the treatment of leukotriene-related disease |
Publications (1)
Publication Number | Publication Date |
---|---|
IL103205A0 true IL103205A0 (en) | 1993-02-21 |
Family
ID=36809157
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL103205A IL103205A0 (en) | 1991-09-19 | 1992-09-17 | Compounds for treating leukotriene-related diseases |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0604529A1 (en) |
JP (1) | JPH06510786A (en) |
CN (1) | CN1092409A (en) |
AP (1) | AP333A (en) |
AU (1) | AU2573592A (en) |
CA (1) | CA2119467A1 (en) |
IL (1) | IL103205A0 (en) |
MA (1) | MA22649A1 (en) |
MX (1) | MX9205358A (en) |
NZ (1) | NZ244371A (en) |
PT (1) | PT100881A (en) |
WO (1) | WO1993006085A1 (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1095713A (en) * | 1992-06-30 | 1994-11-30 | 史密丝克莱恩比彻姆公司 | Make the method for some thioether |
GB9313145D0 (en) * | 1993-06-25 | 1993-08-11 | Smithkline Beecham Plc | Process |
IL115420A0 (en) | 1994-09-26 | 1995-12-31 | Zeneca Ltd | Aminoheterocyclic derivatives |
DE69609820T2 (en) * | 1995-03-02 | 2001-03-08 | Smithkline Beecham Corp | Use of substituted pyridine compounds for the treatment of atopic dermatitis and contact dermatitis |
GB9508137D0 (en) * | 1995-04-21 | 1995-06-07 | Smithkline Beecham Plc | Formulation |
GB9602166D0 (en) | 1996-02-02 | 1996-04-03 | Zeneca Ltd | Aminoheterocyclic derivatives |
US6313127B1 (en) | 1996-02-02 | 2001-11-06 | Zeneca Limited | Heterocyclic compounds useful as pharmaceutical agents |
US5929096A (en) * | 1996-02-29 | 1999-07-27 | Smithkline Beecham Corporation | Method for treating atopic dermatitis and contact dermatitis |
CZ45699A3 (en) * | 1996-08-14 | 1999-05-12 | Zeneca Limited | Substituted pyrimidine derivatives, process of their preparation and pharmaceutical composition containing thereof |
CA2265996A1 (en) | 1996-09-26 | 1998-04-02 | Roger Aki Fujimoto | Aryl-substituted acrylamides with leukotriene b4 (ltb-4) receptor antagonist activity |
UA56197C2 (en) | 1996-11-08 | 2003-05-15 | Зенека Лімітед | Heterocyclic derivatives |
DE69815509T2 (en) | 1997-02-13 | 2004-05-13 | Astrazeneca Ab | HETEROCYCLIC COMPOUNDS THAT APPLY AS OXIDO-SQUALEN-CYCLASE INHIBITORS |
US6440972B1 (en) | 1997-02-13 | 2002-08-27 | Zeneca Limited | Heterocyclic compounds useful as oxido-squalene cyclase inhibitors |
GB9715895D0 (en) | 1997-07-29 | 1997-10-01 | Zeneca Ltd | Heterocyclic compounds |
GB9902989D0 (en) | 1999-02-11 | 1999-03-31 | Zeneca Ltd | Heterocyclic derivatives |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4056619A (en) * | 1975-09-08 | 1977-11-01 | Warner-Lambert Company | 1-Substituted-2-(2-pyridinyl)ethanone N-oxides |
CA1322004C (en) * | 1987-11-25 | 1993-09-07 | Merck Frosst Canada Incorporated | Pyridyl styrene dialkanoic acids |
AU655428B2 (en) * | 1990-06-07 | 1994-12-22 | Smithkline Beecham Corporation | Benzoic acid derivatives |
-
1992
- 1992-09-01 EP EP92920043A patent/EP0604529A1/en not_active Withdrawn
- 1992-09-01 JP JP5506069A patent/JPH06510786A/en active Pending
- 1992-09-01 CA CA002119467A patent/CA2119467A1/en not_active Abandoned
- 1992-09-01 WO PCT/US1992/007466 patent/WO1993006085A1/en not_active Application Discontinuation
- 1992-09-01 AU AU25735/92A patent/AU2573592A/en not_active Abandoned
- 1992-09-08 MA MA22940A patent/MA22649A1/en unknown
- 1992-09-17 IL IL103205A patent/IL103205A0/en unknown
- 1992-09-17 AP APAP/P/1992/000428A patent/AP333A/en active
- 1992-09-17 NZ NZ244371A patent/NZ244371A/en unknown
- 1992-09-18 PT PT100881A patent/PT100881A/en not_active Application Discontinuation
- 1992-09-21 MX MX9205358A patent/MX9205358A/en unknown
-
1993
- 1993-03-19 CN CN93103596A patent/CN1092409A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
CA2119467A1 (en) | 1993-04-01 |
NZ244371A (en) | 1995-11-27 |
MX9205358A (en) | 1993-07-01 |
AP9200428A0 (en) | 1992-10-31 |
EP0604529A1 (en) | 1994-07-06 |
CN1092409A (en) | 1994-09-21 |
WO1993006085A1 (en) | 1993-04-01 |
AU2573592A (en) | 1993-04-27 |
AP333A (en) | 1994-04-25 |
PT100881A (en) | 1993-10-29 |
MA22649A1 (en) | 1993-04-01 |
JPH06510786A (en) | 1994-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0714302A4 (en) | Therapeutic compounds | |
GB9127150D0 (en) | Novel treatment | |
GB9215633D0 (en) | Novel treatment | |
AP9200453A0 (en) | Medicaments for treating inflammatory conditions or for analgiesia | |
IL103205A0 (en) | Compounds for treating leukotriene-related diseases | |
GB9310199D0 (en) | Therapeutic compounds | |
GB9211148D0 (en) | Novel treatment | |
ZA914322B (en) | Pyridyl-benzoic acid derivatives for treating leukotrienerelated diseases | |
AP9400637A0 (en) | Therapeutic c compounds | |
GB9117819D0 (en) | Therapeutic compounds | |
ZA942911B (en) | Therapeutic compounds | |
AP9300527A0 (en) | Novel treatment | |
GB9203637D0 (en) | Novel treatment | |
ZA927160B (en) | Compounds for treating leukotriene-related diseases. | |
GB9214239D0 (en) | Compounds useful for treating tumours | |
GB9124541D0 (en) | Therapeutic compounds | |
GB9102376D0 (en) | Therapeutic compounds | |
GB9102341D0 (en) | Therapeutic compounds | |
GB9102340D0 (en) | Therapeutic compounds | |
GB9000691D0 (en) | Therapeutic compounds | |
GB9020266D0 (en) | Therapeutic compounds | |
GB9226526D0 (en) | Therapeutic compounds | |
GB9222934D0 (en) | Therapeutic compounds | |
GB9114335D0 (en) | Compounds useful for treating tumours | |
GB9127354D0 (en) | Agents for therapy |